(19)
(11) EP 3 448 393 A1

(12)

(43) Date of publication:
06.03.2019 Bulletin 2019/10

(21) Application number: 17723284.0

(22) Date of filing: 25.04.2017
(51) International Patent Classification (IPC): 
A61K 31/7084(2006.01)
A61K 31/708(2006.01)
A61K 9/00(2006.01)
A61P 31/00(2006.01)
 A61K 31/7076(2006.01)
A61K 33/42(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/EP2017/059781
(87) International publication number:
WO 2017/186711 (02.11.2017 Gazette 2017/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 25.04.2016 EP 16305481

(71) Applicant: Invivogen
31400 Toulouse (FR)

(72) Inventors:
  • VERNEJOUL, Fabienne
    31100 TOULOUSE (FR)
  • BOULARAN, Cédric
    31500 TOULOUSE (FR)
  • DROCOURT, Daniel
    31650 SAINT ORENS DE GAMEVILLE (FR)
  • LIOUX, Thierry
    31130 BALMA (FR)
  • QUSHAIR, Grégory
    31000 TOULOUSE (FR)
  • ROMO, Jésus
    ESCONDIDO, CA 92026 (US)
  • TIRABY, Gérard
    31400 TOULOUSE (FR)

(74) Representative: Cabinet Plasseraud 
66, rue de la Chaussée d'Antin
75440 Paris Cedex 09
75440 Paris Cedex 09 (FR)

   


(54) NOVEL COMPLEXES OF IMMUNOSTIMULATORY COMPOUNDS, AND USES THEREOF